Brief: Vaxart Q2 Net Income USD -16.466 Million
08/08/2024 21:01
Aug 08 (Reuters) - Vaxart Q2 operating expenses USD 22.657 million. * Q2 basic EPS USD -0.09 * Q2 operating income USD -16.256 million * Q2 pretax profit USD -16.445 million
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts